Skip to main content
Clinical Trials/NCT05012930
NCT05012930
Active, not recruiting
Not Applicable

Effects of Complementary Feeding on Infant Growth and Gut Health

University of Colorado, Denver1 site in 1 country267 target enrollmentAugust 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gut Microbiome
Sponsor
University of Colorado, Denver
Enrollment
267
Locations
1
Primary Endpoint
Weight
Status
Active, not recruiting
Last Updated
7 months ago

Overview

Brief Summary

This study plans to learn more about how consuming different foods during the time of early complementary feeding (~5 to 12 months) affects growth and the development of bacteria living inside your baby's gut through school-age. The results from this study will potentially help to support future recommendations and dietary guidance for infant feeding practices.

The three primary aims include:

Aim 1. Identify the impact of dietary patterns with different protein-rich foods on infant growth.

Aim 2. Identify the impact of dietary patterns with different protein-rich foods on infant gut microbiota development.

Aim 3. Identify gut microbial taxa and genes that affect infant growth.

Detailed Description

Some details are intentionally left to out to preserve the scientific integrity of the study, and they will be included in the record after the study is completed.

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
July 1, 2027
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Full term;
  • Generally healthy without conditions that would affect protein metabolism or growth
  • No previous complementary food exposure
  • Vaginal delivery
  • No prior exposure of antibiotics during delivery or after birth
  • Able to consume study foods
  • Single birth.

Exclusion Criteria

  • Pre-term infants.
  • Having conditions that would affect normal growth
  • Had complementary foods prior to the start of the study
  • Not willing to consume the complementary foods provided
  • Antibiotics exposure during delivery or from birth to 5 months of life
  • Multiple births

Outcomes

Primary Outcomes

Weight

Time Frame: Over 6 months

Measured in kg

Length

Time Frame: Over 6 months

Measured in cm

Body composition

Time Frame: Over 6 months

Body fat mass, fat-free mass measured by stable isotopes

Gut Microbiome

Time Frame: Over 6 months

Gut microbiota structure by 16S sequencing

Secondary Outcomes

  • Total calories in breast milk(Over 6 months)
  • Total carbohydrates in breast milk(Over 6 months)
  • Total protein in breast milk(Over 6 months)
  • Total fat in breast milk(Over 6 months)
  • Serum IGF-1 (Insulin-like growth factor1/ somatomedin C)(Over 6 months)
  • Serum IGFBP-3 (Insulin-like growth factor-binding protein 3)(Over 6 months)
  • Serum c-reactive protein (CRP-hs)(Over 6 months)
  • Plasma alpha 1-acid glycoprotein (AGP)(Over 6 months)
  • Dietary intake(Over 6 months)
  • Food acceptance(Over 6 months)

Study Sites (1)

Loading locations...

Similar Trials